Skip to main content
. 2024 Sep 9;15(10):e02360-24. doi: 10.1128/mbio.02360-24

TABLE 1.

Description and testing data of the confirmed acute Lyme disease samples from the Lyme Disease Biobank cohorta,b

Sample ID Patient origin EM > 5 cm at enrollment Antibiotic therapy at enrollment (days) B. burgdorferi culture B. burgdorferi
culture fluid
PCR
B. burgdorferi qPCR Whole-cell lysate ELISA C6 peptide ELISA VlsE/
PepC10
Western blot
IgM
Western blot
IgG
Two-tier testing
Result
Initial discriminatory model prediction Tester
Set
Prediction
LYM-997 NY YES YES (1) NA NA NEG RE POS NA POS IT POS POS NA
LYM-1237 NY YES NO NA NA NEG RE POS NA POS IT POS POS NA
LYM-1232 WI YES YES (1) NA NA NEG NA POS POS NEG NEG NEG POS NA
LYM-1227 NY YES NO NO POS NEG NR NEG NA IT NEG NEG POS NA
LYM-1214 WI YES NO NA NA NEG NA POS NA NEG POS POS POS NA
LYM-1206 NY YES NO NA NA NEG BL POS NA POS IT POS POS NA
LYM-1203 NY YES NO NO POS NEG RE POS NA IT IT NEG POS NA
LYM-1200 NY YES YES (1) NO POS NEG RE NEG NA POS IT POS NEG NA
LYM-1199 NY YES NO NO NEG NEG NR POS NA POS IT POS NEG NA
LYM-1191 NY YES YES (1) NA NA NEG RE POS NA POS IT POS POS NA
LYM-1160 MA YES NO NA NA NEG RE POS NA IT IT NEG POS POS
LYM-1131 MA YES NO POS POS NEG NR NEG NA IT IT NEG NEG NA
LYM-1114 NY YES NO NA NA POS NR POS NA IT IT NEG NEG NEG
LYM-1110 NY YES NO NA NA POS NR NEG NA NEG IT NEG POS NA
LYM-1107 NY YES NO NA NA NEG RE POS NA IT POS POS POS NA
LYM-1099 WI YES NO NA NA POS NA NEG NEG NEG NEG NEG NEG NEG
LYM-1097 NY YES YES (10) NA NA NEG RE POS NA POS IT POS POS POS
LYM-1093 WI YES YES (1) NA NA NEG NA POS POS POS NEG POS POS NA
LYM-1034 WI YES YES (1) NA NA NEG NA POS POS POS NEG POS POS NA
LYM-1031 NY YES NO NA NA NEG BL POS NA IT IT NEG POS NA
LYM-1016 MA YES NO NEG NEG NEG RE POS NA POS POS POS POS NA
LYM-1015 MA YES YES (1) NEG NEG NEG NR POS NA POS IT POS POS NA
LYM-1005 NY YES NO NA NA NEG NR POS NA POS IT POS POS POS
LYM-1002 NY YES NO NA NA NEG NR POS NA POS IT POS POS NA
LYM-1001 NY YES NO NA NA NEG RE POS NA IT IT NEG POS NA
LYM-998 NY NO NO NA NA NEG RE POS NA POS IT POS POS POS
LYM-1207 WI NO NO NA NA NEG NA POS NA NEG NEG NEG POS NA
LYM-1181 NY NO NO NA NA NEG NR POS NA POS IT POS POS NA
LYM-1127 NY NO YES (1) NEG NEG NEG RE POS NA IT POS POS POS NA
LYM-1055 NY NO NO NA NA NEG BL POS NA POS IT POS POS NA
LYM-1204 NY NO NO NA NA NEG NR POS NA POS IT POS NEG NA
LYM-1137 MA NO NO NEG NEG NEG RE POS NA POS POS POS POS NA
LYM-1123 NY NO NO NEG NEG NA NR POS NA POS NEG POS POS NA
LYM-1086 WI NO YES (2) NA NA NEG NA POS POS POS NEG POS POS NA
LYM-1080 WI NO NO NA NA NEG NA POS POS POS POS POS POS NA
LYM-1022 WI NO YES (2) NA NA NEG NA NEG POS POS NEG POS POS POS
LYM-1013 NY NO NO NA NA POS BL NEG NA NEG IT NEG NEG NA
LYM-1010 NY NO NO NA NA NEG RE NEG NA POS IT POS POS NA
a

NA: data not available; RE: reactive; NR: not reactive; IT: indeterminate; BL: borderline; POS: positive; NEG: negative; NY; New York; WI: Wisconsin; MA: Massachussetts.

b

Samples with an infection identified by qPCR and/or culture are shown in bold. B. burgdorferi qPCR was performed in whole blood samples.